• XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Wed, 08 Jul 2026 21:04:00 GMT
• Xortx Therapeutics updates investors on kidney disease focus ad-hoc-news.de Tue, 07 Jul 2026 16:50:56 GMT
• XRTX Q1 2024 Earnings: Significant EPS Miss Reflects Preclinical Stage Challenges - Quarterly Earnings dars.gov.et Mon, 06 Jul 2026 04:43:05 GMT
• Enterprise value to revenue forward of XORTX Therapeutics, Inc. – TSXV:XRTX TradingView Sun, 05 Jul 2026 02:55:45 GMT
• Xortx Therapeutics outlines kidney disease focus as clinical-stage biotech ad-hoc-news.de Fri, 03 Jul 2026 11:03:57 GMT
• why xortx therapeutics inc stock is skyrocketing today Wealth Awesome Thu, 02 Jul 2026 18:21:28 GMT
• why xortx therapeutics inc stock is skyrocketing today Wealth Awesome Wed, 01 Jul 2026 18:05:58 GMT
• why xortx therapeutics inc stock is skyrocketing today Wealth Awesome Tue, 30 Jun 2026 18:10:46 GMT
• XRTX Q1 2024 Earnings: EPS Falls Sharply Short of Analyst Expectations - Healthcare Earnings Report dars.gov.et Tue, 30 Jun 2026 17:40:28 GMT
• 12 health care stocks moving in tuesday's pre-market session Benzinga Tue, 30 Jun 2026 12:05:40 GMT
• xortx therapeutics inc (xrtx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 06:12:29 GMT
• xortx therapeutics inc (xrtx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 06:12:20 GMT
• xortx therapeutics inc (xrtx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 03:28:15 GMT
• xortx therapeutics inc (xrtx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 02:22:33 GMT
• xortx therapeutics inc (xrtx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 02:21:33 GMT
• xortx therapeutics q1 2024 earnings: significant eps miss reflects r&d investment, stock gains despite loss newsline.com Wed, 17 Jun 2026 22:44:30 GMT
• xortx therapeutics inc (xrtx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:36:12 GMT
• xortx therapeutics inc (xrtx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 19:58:35 GMT
• xortx therapeutics inc (xrtx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 19:47:19 GMT
• xortx therapeutics (xrtx) slips 0.68% as traders eye key support at $2.06 - covered call etf newsline.com Tue, 16 Jun 2026 23:40:36 GMT
• xortx therapeutics appoints mika grasso as co-ceo; voluntarily delisting from the tsx venture exchange marketscreener.com Mon, 15 Jun 2026 13:45:45 GMT
• xortx therapeutics inc. announces appointment of mika grasso to co-ceo marketscreener.com Mon, 15 Jun 2026 12:20:57 GMT
• XORTX Therapeutics (NASDAQ: XRTX) refocuses on gout program and appoints co-CEO Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• A 28-year-old co-CEO and XORTX's $700M gout push in the US Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• xortx therapeutics providing corporate update and appoints mika grasso as co-ceo marketscreener.com Mon, 15 Jun 2026 07:00:00 GMT
• xortx therapeutics | 6-k: report of foreign private issuer [rules 13a-16 and 15d-16] Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• xortx to voluntarily delist from tsx venture exchange, maintain nasdaq listing The Globe and Mail Sat, 13 Jun 2026 07:00:00 GMT
• xortx therapeutics q1 2024 earnings: wider-than-expected loss amid pre-revenue stage - earnings miss streak newsline.com Fri, 12 Jun 2026 11:40:34 GMT
• XORTX Therapeutics (NASDAQ: XRTX) to voluntarily delist from TSX Venture Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• XORTX drops TSX Venture listing to reduce costs, focus on gout drug Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• xortx announces election to voluntary delist from the tsx venture exchange The Killeen Daily Herald Fri, 12 Jun 2026 07:00:00 GMT
• xortx therapeutics stock (us98420x1046): shares under pressure after recent reverse split Ad-hoc-news.de Mon, 01 Jun 2026 07:00:00 GMT
• xortx therapeutics (xrtx) slides over 3% as biotech stock tests key support levels - trend reversal picks newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• XORTX Therapeutics (XRTX) Holds Near Support in Quiet Trading Session - Key Reversal Day dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• XORTX Therapeutics (XRTX) Edges Higher as Stock Holds Above Key Support - Schiff Line dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• xortx therapeutics (xrtx) gains 5.3% as biotech volume picks up – key levels in focus - fade trade newsline.com Fri, 29 May 2026 07:00:00 GMT
• xrtx q1 2024 earnings: steep eps miss highlights pre‑revenue r&d costs, shares climb - pre-earnings setup newsline.com Thu, 28 May 2026 07:00:00 GMT
• XORTX Therapeutics (XRTX) Gains 1.27% as Shares Test Key Resistance Level - Long Short Pair dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• xortx therapeutics q1 2024 earnings: steep eps miss highlights pre‑revenue biotech hurdles - guidance upgrade report newsline.com Fri, 22 May 2026 07:00:00 GMT
• xortx therapeutics stock (us98420x1046): capital raise and kidney disease focus draw investor attent AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• xortx raises us$5 million in public offering to fund kidney and gout drug programs The Globe and Mail Wed, 20 May 2026 07:00:00 GMT
• xortx therapeutics raises us$5 million via public offering marketscreener.com Tue, 19 May 2026 12:16:20 GMT
• XORTX Announces Closing of US$5 Million Public Offering GlobeNewswire Tue, 19 May 2026 07:00:00 GMT
• xortx therapeutics (nasdaq: xrtx) closes us$5m share and pre-funded warrant deal Stock Titan Tue, 19 May 2026 07:00:00 GMT
• xortx raises us$5m, earmarks us$2.5m for investor marketing Stock Titan Tue, 19 May 2026 07:00:00 GMT
• E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering GlobeNewswire Mon, 18 May 2026 07:00:00 GMT
• xortx (nasdaq: xrtx) posts q1 2026 loss, adds vb4-p5 asset and launches $5m equity raise Stock Titan Mon, 18 May 2026 07:00:00 GMT
• xortx therapeutics inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Sat, 16 May 2026 02:20:00 GMT
• xortx therapeutics inc expected to post a loss of c$1.64 a share - earnings preview TradingView Fri, 15 May 2026 07:00:00 GMT
• xortx (nasdaq: xrtx) raises ~$4.7m via share sale and pre-funded warrants Stock Titan Fri, 15 May 2026 07:00:00 GMT
• xortx therapeutics 2.66m share spot secondary priced at $1.88 TipRanks Thu, 14 May 2026 21:33:06 GMT
• xortx therapeutics raising us$5 million in a public offering; shares down 8.9% marketscreener.com Thu, 14 May 2026 18:18:15 GMT
• xortx announces us$5 million public offering | associated press | syndication news Enidnews.com Thu, 14 May 2026 11:02:41 GMT
• xortx (nasdaq: xrtx) prices us$5m public equity and warrant deal Stock Titan Thu, 14 May 2026 07:00:00 GMT
• kidney drug developer xortx prices us$5m nasdaq share sale Stock Titan Thu, 14 May 2026 07:00:00 GMT
• xortx therapeutics stock (us98420x1046): biotech advances kidney disease treatments AD HOC NEWS Tue, 12 May 2026 14:48:57 GMT
• xortx says preliminary equity levels meet nasdaq listing threshold The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
• xortx (nasdaq: xrtx) estimates $4.1m equity, above nasdaq minimum Stock Titan Fri, 08 May 2026 07:00:00 GMT
• 1.8m-share offering — xortx therapeutics (nasdaq: xrtx) files f-1 amendment Stock Titan Fri, 08 May 2026 07:00:00 GMT
• xrtx xortx therapeutics posts far wider q1 2024 loss than estimates, shares fall 1.85% amid elevated rd spending. newsline.com Tue, 05 May 2026 07:00:00 GMT
• xortx shareholders approve up-to-5-for-1 share consolidation to meet nasdaq rules MSN Sun, 26 Apr 2026 11:13:53 GMT
• xortx shareholders approve up-to-5-for-1 share consolidation to meet nasdaq rules MSN Sat, 25 Apr 2026 07:00:32 GMT
• xortx therapeutics (xrtx) stock: pricing efficiency review | q1 2024: earnings fall short - community exit signals Newser Sat, 25 Apr 2026 03:51:20 GMT
• xortx therapeutics (xrtx) stock: pricing efficiency review | q1 2024: earnings fall short - segment revenue breakdown Newser Fri, 24 Apr 2026 07:00:00 GMT
• xortx therapeutics | pos am: post-effective amendment to a registration statement that is not immediately effective upon filing - ... Moomoo Thu, 23 Apr 2026 07:00:00 GMT
• xortx therapeutics (nasdaq: xrtx) registers up to 2.2m shares; $4.7m estimated proceeds Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• xortx therapeutics (nasdaq: xrtx) files f-1: 2.2m shares, pre-funded warrants Stock Titan Wed, 22 Apr 2026 12:47:41 GMT
• xrtx sec filings - xortx therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Wed, 22 Apr 2026 07:07:28 GMT
• xortx regains nasdaq listing compliance after reverse stock split The Globe and Mail Wed, 22 Apr 2026 07:00:00 GMT
• xrtx stock jumps as vb4-p5 kidney deal expands pipeline StocksToTrade Tue, 21 Apr 2026 19:29:00 GMT
• xortx therapeutics says met nasdaq continued listing requirements marketscreener.com Tue, 21 Apr 2026 11:20:25 GMT
• after 1-for-5 reverse split, xortx clears nasdaq $1 bid rule Stock Titan Tue, 21 Apr 2026 11:00:00 GMT
• XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split Quiver Quantitative Tue, 21 Apr 2026 07:00:00 GMT
• XRTX Stock Jumps As Kidney Pipeline Expands With VB4-P5 Deal StocksToTrade Tue, 21 Apr 2026 07:00:00 GMT
• XRTX Jumps As New Kidney Fibrosis Deal Expands Pipeline timothysykes.com Tue, 21 Apr 2026 07:00:00 GMT
• xortx (nasdaq: xrtx) cures nasdaq minimum bid deficiency Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• xortx therapeutics (nasdaq: xrtx) files f-1: 2.2m shares, pre-funded warrants Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• promising penny stocks to add to your watchlist - april 21st MarketBeat Tue, 21 Apr 2026 07:00:00 GMT
• xortx therapeutics meets nasdaq continued listing requirements TipRanks Tue, 21 Apr 2026 07:00:00 GMT
• xortx therapeutics stock (us98420x1046): is its kidney disease focus strong enough to unlock biotech AD HOC NEWS Mon, 20 Apr 2026 14:16:33 GMT
• After 1-for-5 reverse split, XORTX clears Nasdaq $1 bid rule Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• xortx therapeutics (xrtx) stock: insider signals (smart money outflows) 2026-04-20 - bull pennant newsline.com Mon, 20 Apr 2026 07:00:00 GMT
• xortx (nasdaq: xrtx) closes $3m vb4-p5 kidney anti-fibrotic deal Stock Titan Thu, 16 Apr 2026 07:00:00 GMT
• discontinued operations of xortx therapeutics, inc. – dus:anu TradingView — Track All Markets Tue, 14 Apr 2026 18:28:10 GMT
• long term debt to total equity ratio of xortx therapeutics, inc. – dus:anu TradingView Tue, 14 Apr 2026 17:27:11 GMT
• xortx therapeutics stock (us98420x1046): why does its kidney disease focus matter more now for inves AD HOC NEWS Tue, 14 Apr 2026 13:50:25 GMT
• hedge fund moves: what is the target price for xortx therapeutics inc stock - product launch & free expert verified stock movement... baoquankhu1.vn Mon, 13 Apr 2026 07:27:39 GMT
• XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset GlobeNewswire Mon, 13 Apr 2026 07:00:00 GMT
• 12 health care stocks moving in monday's after-market session Benzinga Mon, 13 Apr 2026 07:00:00 GMT
• vectus biosystems sells renal fibrosis drug to xortx for strategic equity stake TipRanks Mon, 13 Apr 2026 07:00:00 GMT
• is xortx therapeutics inc vulnerable to short sellers - 2026 price action summary & real-time volume analysis baoquankhu1.vn Fri, 10 Apr 2026 16:53:22 GMT
• aug update: can xortx therapeutics inc continue delivering strong returns - weekly trade report & free expert verified stock movem... baoquankhu1.vn Thu, 09 Apr 2026 16:15:53 GMT
• bond watch: is xortx therapeutics inc a speculative investment - wall street watch & low risk entry point tips baoquankhu1.vn Thu, 09 Apr 2026 07:29:08 GMT
• long term debt to total equity ratio of xortx therapeutics, inc. – tradegate:anu TradingView — Track All Markets Thu, 09 Apr 2026 06:52:18 GMT
• xortx therapeutics inc. r (anua.mu) analyst insights, price targets & recommendations Yahoo! Finance Canada Thu, 09 Apr 2026 00:53:31 GMT
• xortx therapeutics, inc. revenue breakdown – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 20:50:47 GMT
• tangible book value per share of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 20:12:25 GMT
• xortx therapeutics, inc. balance sheet – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 19:51:24 GMT
• xortx therapeutics, inc. dividends – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:50:59 GMT
• discontinued operations of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:30:17 GMT
• operating margin % of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:20:42 GMT
• ebitda margin % of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:15:24 GMT
• equity in earnings of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:14:27 GMT
• gross profit of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 18:13:20 GMT
• cash from investing activities of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:53:10 GMT
• preferred dividends of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:51:40 GMT
• xortx therapeutics, inc. cash flow – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:51:30 GMT
• price to earnings ratio of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:41:43 GMT
• net income before discontinued operations of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:41:10 GMT
• long term debt to total assets ratio of xortx therapeutics, inc. – lsx:a427mj TradingView Wed, 08 Apr 2026 17:31:38 GMT
• ebit per share of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:23:54 GMT
• ebitda margin % of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:14:15 GMT
• net margin % of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:05:51 GMT
• enterprise value to ebitda ratio of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 17:04:32 GMT
• net current asset value per share of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:51:30 GMT
• non-controlling/minority interest of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:48:03 GMT
• price to sales ratio of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:47:07 GMT
• price to cash flow ratio of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:43:13 GMT
• diluted shares outstanding of xortx therapeutics, inc. – lsx:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:31:24 GMT
• price to book ratio of xortx therapeutics, inc. – ls:a427mj TradingView — Track All Markets Wed, 08 Apr 2026 16:19:48 GMT
XORTX Therapeutics(NASDAQ:XRTX) 
